Capsaicin-sensitive afferentation represents an indifferent defensive pathway from eradication in patients with H. pylori gastritis

doi:10.4292/wjgpt.v2.i5.36

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3621)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

433

HTML

2825

Figures (1-2)

204

Tables (1-2)

159

Sum=3621

Oct 6, 2011 (publication date) through Aug 2, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastrointest Pharmacol Ther. Oct 6, 2011; 2(5): 36-41
Published online Oct 6, 2011. doi: 10.4292/wjgpt.v2.i5.36

Table 2 Summary of the presence of capsaicin receptor, calcitonin gene-related peptide and substance P in the gastric mucosa of patients with chronic Helicobacter pylori positive gastritis, before and after eradication therapy, obtained by immunohistochemistry n (%)

	TRVP1		CGRP		Substance P
	Positive	Negative	Positive	Negative	Positive	Negative
Before eradication (n = 18)	16 (88.89)	2 (11.11)	18 (100)	0 (0)	1 (5.56)	17 (94.44)
After eradication (n = 18)	13 (72.22)	5 (17.78)	18 (100)	0 (0)	0 (0)	18 (100)
Control group (n = 20)	7 (35)	13 (65)	8 (40)	12 (60)	15 (75)	5 (25)

CGRP: Calcitonin gene-related peptide; TRVP1: Transient receptor potential vanilloid 1.

Citation: Lakner L, Dömötör A, Tóth C, Szabó IL, Meczker &, Hajós R, Kereskai L, Szekeres G, Döbrönte Z, Mózsik G. Capsaicin-sensitive afferentation represents an indifferent defensive pathway from eradication in patients with H. pylori gastritis. World J Gastrointest Pharmacol Ther 2011; 2(5): 36-41
URL: https://www.wjgnet.com/2150-5349/full/v2/i5/36.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v2.i5.36